Last updated on August 22nd, 2021 at 01:11 PM
Who will be the first to receive an effective vaccine against coronavirus in the UK?
How can we be sure that clinical trials are still safe while working as quickly as possible to develop a vaccine?
How can you sign up to be contacted about future clinical trials and what should you expect as a participant?
These questions, and many others are answered by guests of the latest episodes from the Vaccines Taskforce podcast.
In Episode 2 – Vaccine and Trial Safety is discussed with Kate Bingham, Chair of the UK Vaccines Taskforce, Dr Jonathan Sheffield, National Institute for Health Research / Department of Health and Social Care COVID-19 Liaison Director and Dr Phil Bryan, Head of Vaccine Safety at the Medicines and Healthcare Products Regulatory Agency
In Episode 3 – UK Vaccine Strategy is explored when Neil McNeil talks to Kate Bingham, Chair of the UK Vaccines Taskforce, Dr Mary Ramsey, Head of Immunisation at Public Health England, and Dr Na’eem Ahmed of NHS England about the many essential criteria that must be considered before a decision is reached.
All episodes of the podcast are available at the following links on iTunes and Spotify:
The next episode will discuss how we ensure that we have global equitable access for any successful vaccine.